/
Dermatology
232Diseases↗
556Pipeline Programs↗
634Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
2,525
clinical trials
Completed1,398 · 55%
Recruiting298 · 12%
Unknown status249 · 10%
Not yet recruiting169 · 7%
Terminated149 · 6%
Active, not recruiting143 · 6%
Other119 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
17programs
15programs
14programs
10programs
7programs
Landscape
Diseases
Dermatitis
Most programs126
Programs
228
Trials
7
Recruiting
Pre
13
P1
1
P2
1
P3
—
Appr
6
Most programs:
AbbVie
AbbVieAlopecia
Most trials25
Programs
103
Trials
4
Recruiting
Pre
2
P1
1
P2
1
P3
1
Appr
5
Most programs:
Jazz Pharmaceuticals
Jazz PharmaceuticalsScar
Highest activity6
Programs
113
Trials
3
Recruiting
Pre
5
P1
—
P2
—
P3
—
Appr
—
Plaque Psoriasis
14 programs104 trialsPhase 3
Burn
48 programs106 trialsApproved
Hidradenitis Suppurativa
336 programs66 trialsApproved
Vitiligo
330 programs61 trialsApproved
Acne
13 programs69 trialsApproved
Hidradenitis
0 programs66 trials
Urticaria
226 programs38 trialsApproved
Moderate-to-Severe Plaque Psoriasis
3 programs58 trialsPhase 3
Chronic Spontaneous Urticaria
118 programs27 trialsApproved
Androgenetic Alopecia
212 programs28 trialsApproved
Epidermolysis Bullosa
13 programs25 trialsApproved
Acne Vulgaris
26 programs30 trialsPhase 3
Lichen Planus
13 programs19 trialsApproved
Non-Segmental Vitiligo
24 programs28 trialsPhase 3
Prurigo Nodularis
11 programs15 trialsApproved
Psoriasis Vulgaris
18 programs7 trialsApproved
Keloid
9 programs15 trialsApproved
Oral Lichen Planus
8 programs14 trialsApproved
Warts
11 program21 trialsPhase 2
Rosacea
10 programs11 trialsApproved
Eczema
11 program19 trialsPhase 3
Actinic Keratosis
6 programs13 trialsApproved
Contact Dermatitis
12 programs5 trialsApproved
Severe Alopecia Areata
12 programs15 trialsPhase 3
Atopic Eczema
12 programs4 trialsApproved
Melasma
0 programs16 trials
Dystrophic Epidermolysis Bullosa
4 programs10 trialsPhase 3
Showing top 30 diseases by activity. 202 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)